Henry Schein this week announced three additions to its leadership team.
The Melville, N.Y.–based medical and dental supplies distributor appointed Steve Boggan and Bianka Wilson as co-CEOs of its global oral reconstruction group (GORG) and Tom Popeck as CEO of its healthcare specialties group (HSG).
GORG is the company’s portfolio of premium value and value implant lines with a full range of biomaterial products. The HSG includes a range of the company’s manufacturing brands in the high-growth endodontic, orthodontic and orthopedic markets.
“We are delighted to welcome three strong and proven leaders to the Henry Schein Executive Management Committee,” CEO Stanley Bergman said in a news release. “Steve, Bianka, and Tom have each demonstrated vision and commitment in inspiring and leading our teams to excellence in a quickly changing global healthcare marketplace. Our senior leadership team will benefit greatly from the added perspectives of these seasoned professionals.”
The GORG and HSG businesses are a part of the company’s BOLD+1 strategic plan to build higher-growth, higher-margin specialty products and services to complement Henry Schein’s distribution, software and value-added businesses.
More about the new executives
Boggan joined Henry Schein in 2013 when the company acquired BioHorizons. He was at BioHorizons since 1995 and had led as president and CEO since 1999. As a Co-CEO of GORG, Boggan will lead commercial operations in North and South America and the Middle East, and global marketing.
Wilson joined the company in 2018 after 25 years in finance and consulting. She was CFO of Henry Scheins GORG. Prior to joining the company, she served as group CFO of Ascom Holding, a Swiss public company in the medical communication technology sector. She was also an advisor and global account lead partner at KPMG. As co-CEO, Wilson will lead strategy, finance, and human resources, as well as the group’s business in Europe and APAC.
Popeck has been with Henry Schein since 2019 with more than 20 years of sales leadership and general management experience. Before joining the company, he spent over two decades leading businesses in orthopedics and industrial manufacturing, including 11 years at Stryker. In 2023, he was named president of Henry Schein’s HSG.
